Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2022-09-20 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 100% confidence The document is a Management Certification related to Form 13-502F1 for Class 1 and Class 3B Reporting Issuers, submitted to the Ontario Securities Commission. It contains officer certification by the CFO, Glen Ibbott, certifying the completeness and accuracy of the information provided. The content focuses on participation fees, market values, and trading periods, but does not include financial statements or substantive financial data typical of financial reports. The document is primarily a certification and fee calculation submission to a regulatory body, not a full financial report or announcement of financial results. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing financial data, should be classified as Regulatory Filings (RNS).
2022-09-20 English
News release - English.pdf
Regulatory Filings
2022-09-20 English
Notice of the meeting and record date - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General and Special Meeting of Aurora Cannabis Inc. It provides details such as meeting type, record dates, meeting date, and voting security details. The document is short (1173 characters) and serves as an announcement about the meeting and proxy materials, not the meeting materials themselves or voting results. It does not contain financial data, management discussion, or voting results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is about the meeting notice and proxy material delivery, it aligns best with Proxy Solicitation & Information Statement (PSI).
2022-08-27 English
News release - English.pdf
Regulatory Filings
2022-08-25 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Aurora Cannabis has repurchased a portion of its convertible senior notes to reduce debt and interest costs. It discusses the transaction details, the company's balance sheet strength, and forward-looking statements about future financial performance. There are no financial statements, detailed financial data, or comprehensive report content. The document is an update on a capital/financing activity (debt repurchase). It is not an earnings release, annual or interim report, or audit report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (6266 characters) supports it being a full announcement rather than a brief notice or regulatory filing. Confidence is high given the clear focus on debt repurchase and financing update.
2022-06-03 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a consent letter from KPMG LLP addressed to various Canadian securities commissions regarding the use of their audit reports in a prospectus supplement dated May 27, 2022. It references audit reports dated September 27, 2021, on consolidated financial statements and internal control over financial reporting as of June 30, 2021. The document explicitly states it is a consent to use the audit reports in a prospectus for a securities offering. It does not contain the audit report itself, nor does it include financial statements or substantive financial data. The document length is 2884 characters, which is relatively short and consistent with a consent letter rather than a full audit report. According to the rules, officer certifications, attestations, or consent letters—even if referencing audit reports—should be classified as Regulatory Filings (RNS). Therefore, this document is best classified as a Regulatory Filing (RNS).
2022-05-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.